These sub-analyses suggest that finerenone may blunt the pro-inflammatory and pro-fibrotic effects of MR, preventing and slowing the progression of atrial and ventricular detrimental remodeling associated with aldosterone and eventually related to the development of HF and AF. The gene discussed is NR3C2; the disease is hydrops fetalis.